{"transactions":[{"id":3767151,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":162489,"kind":"person","name":"Windisch Joerg","position":1,"cik":"0001735528","reported_name":"Windisch Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-13T16:57:57.000Z","date":"2018-11-09","kind":"grant","acquired":true,"shares":130465,"price":0.613,"value":79975.045,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This option was issued to the Reporting Person pursuant to the Issuer's 2015 Equity Incentive Plan in lieu of two years of cash retainer and meeting fees of $80,000."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately exercisable."}],"balance_after":130465,"derivative":{"exercise_price":0.89,"expiration_date":"2028-11-09","underlying":"Common Stock","underlying_shares":130465},"source":{"system":"sec-edgar","filing":"0001209191-18-058305","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735528/000120919118058305/doc4.xml","form_type":"4"}},{"id":3808356,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":162489,"kind":"person","name":"Windisch Joerg","position":1,"cik":"0001735528","reported_name":"Windisch Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-25T16:58:19.000Z","date":"2018-09-21","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying the option shall vest on September 21, 2019, subject to the Reporting Person providing continuous service to the Issuer on such date."}],"balance_after":15000,"derivative":{"exercise_price":0.9155,"expiration_date":"2028-09-21","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-18-052156","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735528/000120919118052156/doc4.xml","form_type":"4"}},{"id":3982067,"issuer":{"id":608,"kind":"organization","name":"Outlook Therapeutics, Inc.","symbol":"OTLK"},"owners":[{"id":162489,"kind":"person","name":"Windisch Joerg","position":1,"cik":"0001735528","reported_name":"Windisch Joerg","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-27T17:19:20.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33.33% of the shares underlying the option shall vest on each of the first, second and third anniversaries of the grant date, such that 100% of the shares underlying the option shall be vested on March 23, 2021, subject to the Reporting Person providing continued service through such date."}],"balance_after":25000,"derivative":{"exercise_price":0.94,"expiration_date":"2028-03-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-18-021775","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1735528/000120919118021775/doc4.xml","form_type":"4"}}]}